{"name":"MediciNova","slug":"medicinova","ticker":"","exchange":"","domain":"medicinova.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"MN-001 BID","genericName":"MN-001 BID","slug":"mn-001-bid","indication":"Other","status":"phase_2"},{"name":"MN-166","genericName":"MN-166","slug":"mn-166","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"MN-001 BID","genericName":"MN-001 BID","slug":"mn-001-bid","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"MN-166","genericName":"MN-166","slug":"mn-166","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMixAJBVV95cUxOTWRKUFFxSkZqdnVqMGlXaEVwaWtLV0dJc21RU2tqeGZpSzhhbEplcWFNUG8zVlk4OE9UVW56VmY0NmJkYjJTTTE0M3oxNlhteE1pNk1IQXhzZzVmTTZYNkVFR2tXMmlDdl84c1c5RHBSQU4wTDFhNzlCVDY5SldIcTBreHg0NnlRR0E0Q0hNM2xMRU43bXMwS0lkbGRKSzhHY2pWVkw2T29zd2w5TEItSW1uQjE5ejVOcmdZNWRQOTZfeFZyUEZucG9jZlZUMk9DMkhacVVPVngyU19ia04tUV9KZTZjM2duUldRN1Yzb2NraTB3VW5mbm9odEpJSEZxS2NvOWlZLThzaTRaWF9uZE9IRmVXd0d2YXVmRUhIOEtIaVItOVJzSGF6M0hDY3dENVhDODQzMzZ6U1BkWWlOdDM5Q2U?oc=5","date":"2026-04-08","type":"pipeline","source":"Barchart.com","summary":"Diabetes Market: Rapid Increment Driven by Innovation by 2032 – DelveInsight | Eli Lilly and Company, Regor Pharma AstraZeneca, Eccogene, Pfizer, Sciwind Biosciences USA Co., Ltd., MediciNova - Barcha","headline":"Diabetes Market: Rapid Increment Driven by Innovation by 2032 – DelveInsight | Eli Lilly and Company, Regor Pharma Astra","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQalVIMVBibzhkbmVVVTduT0tmdjZvdHZpZW9TemZjM2dDdDFxelRpZDRRbzUzay1mWFNJeExtbzlGd3c4SEl4S0ItNlZVeTV5MV9sU1Yxd0dpRzJpMTR5ODZfVG1Gb3ZGTEhDcXVFdmNUb3BPdlc1d2JXaC1yOW9TcnkyNnc0OUpEck56LThzOWlxclJFN1NLNk1qLXV4b1J3c1R1S0JHYzJZV3pVeXc0bVNOcmJ4MGVEM08tZVJVMDZjMFE?oc=5","date":"2026-03-20","type":"pipeline","source":"AD HOC NEWS","summary":"MediciNova Inc stock draws attention amid biotech pipeline momentum and analyst upside calls - AD HOC NEWS","headline":"MediciNova Inc stock draws attention amid biotech pipeline momentum and analyst upside calls","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxORDNNSEx6VVN0eTF2Zk9ORTZhSm1wT0RjbVlYdnF4ZU9IWmh1NGdwTkdIdDJVUlVKWkk5SnNPV3dXQmE1dE9CM0FVVU5YZFl6UkRrdzI2N0NoX1BJZUJyQkhxNWhMTnZJY3dUZ2tOZ2NhY3U4X3R0VDlMQWtNblRPV0todGRDNTFXaEtpLVU4YTRwRWdVNmtHaVdmTU50dG9fY0F5WXRKRzdfTkpIQkEzbkV4d3EwZXgx?oc=5","date":"2026-03-15","type":"trial","source":"AD HOC NEWS","summary":"MediciNova Inc Stock (ISIN: US58468P2038) Surges on Clinical Trial Momentum—Analysts See 469% Upsi - AD HOC NEWS","headline":"MediciNova Inc Stock (ISIN: US58468P2038) Surges on Clinical Trial Momentum—Analysts See 469% Upsi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxPOUdVMVNLcDQ2di1VREUzVFpET0RwSjBwbUZ6QTBObVgzT3g2Z1UyWklZV3l1ZURVZjJNVWJQbV8wYXVuc3dpUWFLTVpJX1l0dWhBMDZJNUw3Y0tVZXBXSldCMEQ3cURFYXlScWNMUkxXSlpoRmkxQzhUeFFfWDBJVDRfTlZJbURNem9KdEh0X25wTVNacTctOWRrZzdrN1NFc3ZreWRRdWx6Mzh0ZFJkUWpHZXRsSlBUNjFvdEJzZl83aUk?oc=5","date":"2026-02-02","type":"trial","source":"Streetwise Reports","summary":"Drug Developer Uncovers Excellent Progress in 200-Patient ALS Study - Streetwise Reports","headline":"Drug Developer Uncovers Excellent Progress in 200-Patient ALS Study","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-20","type":"pipeline","source":"PR Newswire","summary":"Alcohol Use Disorder Market to Grow Rapidly at a 13.6% CAGR by 2034 Owing to Rising Disease Prevalence, Significant Advancements in Genetically-targeted Therapies, along with Innovative Treatments suc","headline":"Alcohol Use Disorder Market to Grow Rapidly at a 13.6% CAGR by 2034 Owing to Rising Disease Prevalence, Significant Adva","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-03","type":"pipeline","source":"simplywall.st","summary":"3 Penny Stocks With Market Caps Over $80M To Consider - simplywall.st","headline":"3 Penny Stocks With Market Caps Over $80M To Consider","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxPekRQaFB1b2FhNW9HZnZSU1poQTJVc1V2d1lmNGI2ZkZsNmg4VG1FYl8zTkpjOEh5S19wZWQzbEc0My1LQVpmRjhzcDVsb0FkWHpSRnZIM3k5REN1QXFQcTVudmo0WHREbDQyeDl6UmgwZEdaa1dKZE0waERxWDZLa0dNa2lkaVdURnlfN0l3?oc=5","date":"2025-10-31","type":"pipeline","source":"Pharma Voice","summary":"One of the few late-stage ALS contenders hits a critical juncture - Pharma Voice","headline":"One of the few late-stage ALS contenders hits a critical juncture","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE1DbTFFZGZRMDJDVHRQZmR3ODllMDJxOFRrX05YdXVMa0Y5MjFGdGdXcFNHbHpIQWV2RmswNzRPVTIwdVFvYnJVVmpnTjYzbU1mdm1n?oc=5","date":"2025-04-24","type":"pipeline","source":"Stock Titan","summary":"MNOV Stock Price, News & Analysis - Stock Titan","headline":"MNOV Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgJBVV95cUxPODR6a0JUUjQ2d3pHa2c0M3gtN2ZRMDVGandaRFJha3VIMjg3OEdjWTRZTk1uMlV4Z3ktQUhXZGgxNW9oYmRPQ29NSlpwYklHenlyOElhTnhHTENKZldhZ1JiZ3RWU19CLW5vRUVGWEpneEs4dGY5V1gxRnhHanA2Ni1qQno5SnkyZG40dWxyYWVzVFM4Z2hKaHJqTlg2OEkzTnhMd0hveW5vdEhiRENMVEFxTlVtV1ZwejdjVHhnVlYtR1lhbDVuRzU3YlVETDR3bjhhZm40LWVNcUpKQVdpY2FHZl9JTWQ2VDVRR19KdjFVd1o5RUQzOERDMkZQcEpLWTNwZVJtcjgzR2ppYUJRS01kMnUxOUpLSDlwWFVHT19EaVZDSFhaS2F5cHpNa0MwZjcwVXY1X0dSejgwNUE?oc=5","date":"2025-01-28","type":"trial","source":"GlobeNewswire","summary":"Pulmonary Fibrosis Clinical Trial Pipeline Appears Robust - GlobeNewswire","headline":"Pulmonary Fibrosis Clinical Trial Pipeline Appears Robust","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFA0d3BvQzJJZ2VraFpzVURHREpzRHJrYXZmZzdzSHlLZkZ0aHAtcXlwRnhZS3YzUk5KNWU1Q0JVR0Nwa1hFMEtvMXJMQUR2Y0ZwbUs1UXFfd1BtaHN2aFRj?oc=5","date":"2020-02-09","type":"pipeline","source":"ChartMill","summary":"MNOV Stock Price, Quote & Chart | MEDICINOVA INC (NASDAQ:MNOV) - ChartMill","headline":"MNOV Stock Price, Quote & Chart | MEDICINOVA INC (NASDAQ:MNOV)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNTmZXcS1LaWxiZU03VWZONkNpSDVyQ0tPdmJUTzBseFkxUUNMR2Nwd3lKMXpXYmVoRjRnQUt6RGpfX3liTmV4SUIwdm1welFfVC1aX0tsRktmTE93dW16V2lwcnFmWEtqZlZXbmtQUHlJQUVwZ2pxTTZuSjZPaUd6LVJSMlJfbkxIalBLTG5na290cEZvQjNBQWx0aTRLOU05UWppTUdfSzVEcWxPQ2VmcWJEMS1CanFJcE9iLUlGMDg?oc=5","date":"2019-08-24","type":"pipeline","source":"Fortune Business Insights","summary":"Chemotherapy Induced Peripheral Neuropathy Treatment Market Size, 2034 - Fortune Business Insights","headline":"Chemotherapy Induced Peripheral Neuropathy Treatment Market Size, 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxNS1c0WEdYZUpzcVFfMFc1ZkVhOFlNR1BfcXRkOW1TbWYzSDZIZWxEbWJObDlYN3BOVmtJLWJ1WFM5dEFPaXlrRnVza0laM1JrdDllbXFGSEpVVmx0b1JudTZFVU8tQWZ4T2M4c1VaeV9YUGVWZk1xa1BaWHFGcjBLbU11VEYtQWxyaUE?oc=5","date":"2016-12-29","type":"trial","source":"Pulmonary Fibrosis News","summary":"Tipelukast (MN-001) Idiopathic Pulmonary Fibrosis | Clinical Trials - Pulmonary Fibrosis News","headline":"Tipelukast (MN-001) Idiopathic Pulmonary Fibrosis | Clinical Trials","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":2},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}